Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate-specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening history. METHO...
المؤلفون الرئيسيون: | Vickers, A, Cronin, A, Aus, G, Pihl, C, Becker, C, Pettersson, K, Scardino, P, Hugosson, J, Lilja, H |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2010
|
مواد مشابهة
-
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
حسب: Vickers, A, وآخرون
منشور في: (2008) -
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
حسب: Scardino Peter T, وآخرون
منشور في: (2008-07-01) -
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
حسب: Zackrisson, B, وآخرون
منشور في: (2003) -
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
حسب: Hugosson, J, وآخرون
منشور في: (2003) -
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
حسب: Vickers, A, وآخرون
منشور في: (2010)